Proactive Investors - Run By Investors For Investors

THC Global has full suite of cannabis licences to advance farm-to-pharma model

In addition to its core Australian medicinal cannabis assets, THC has a significant Canadian presence – both in cannabis and in hydroponics equipment.
Ken Charteris
Group CEO Ken Charteris at the company's cannabis cultivation site at Bundaberg, Queensland. Photo credit: ABC Wide Bay, Kallee Buchanan

THC Global Group Ltd (ASX:THC) operates under a farm-to-pharma pharmaceutical model, now holding all three key cannabis licences being a Cannabis Research Licence, a Medicinal Cannabis Licence (Cultivation), and a Manufacture Licence.

The company has secured a significant cannabis growing capacity over multiple cultivation projects and owns a pharmaceuticals bio-manufacturing facility with attached testing and product development laboratory.

Bundaberg cannabis cultivation site manager John Hall. Photo credit: ABC Wide Bay, Kallee Buchanan

THC is in a prime position to commence medicinal cannabis production to service both domestic patients and the global export market.

The company is active globally with operations in Australia, New Zealand, and Canada and partnerships across Europe, Asia, and the Middle East.

In addition to its core Australian medicinal cannabis assets, THC has a significant Canadian presence – both in cannabis and in hydroponics equipment.

 

THC’s Canadian cannabis operation, Vertical Canna, holds property in Nova Scotia, Canada being developed into a large-scale cannabis production site.

The company’s hydroponics equipment division, Crystal Mountain, is a revenue generating manufacturer, wholesaler, and retailer of hydroponics equipment and supplies.

View full THC profile View Profile

THC Global Group Ltd Timeline

Related Articles

test tubes
May 03 2019
Proactive takes a closer look at an innovative drugs company that has largely flown under the radar
human kidneys
May 06 2019
The Danish company is seeking FDA approval of the test for use in both adults and children
woman's face
Tue
Here we take a closer look at SkinBioTherapeutics, the life sciences group that is using bacteria to improve people’s skin

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use